Dr. James C. Blair – CEO: Jim has more than 40 years of experience with venture and emerging growth companies. He has been involved in the creation and successful development at the board level of more than 40 life sciences ventures, including Amgen, Aurora Biosciences, Amylin Pharmaceuticals, Applied Biosystems, Cadence Pharmaceuticals, Dura Pharmaceuticals, GeneOhm Sciences, Molecular Dynamics, NuVasive, Pharmion and Volcano. Present board memberships include Applied Proteomics, Astute Medical, aTyr Pharma, ChromaCode, Clovis Oncology, IntegenX, and Ocunexus. Additionally, Jim currently serves on the board of directors of the Prostate Cancer Foundation and the Sanford-Burnham Medical Research Institute. He is also on the advisory boards of the Department of Molecular Biology at Princeton University, the USC Stevens Institute for Innovation, and the Caltech Division of Chemistry and Chemical Engineering.
Dr. Fei Yang – Vice President of Research, Cofounder: Fei is an expert in the Py-Im polyamide technology platform. He has over 9 years of experience working on all aspects of Py-Im polyamide research ranging from synthesis to biological characterization. At Gene Sciences, Fei is responsible for managing the manufacture of our lead candidate working with the contract manufacturing organizations as well as the CMC consultants. He is also leading the research efforts directed at the expansion of the polyamide platform within Gene Sciences.
Lynne Rollins – CFO: Lynne has over 25 years of experience in accounting and finance, and has worked with numerous startup companies. At Gene Sciences, she is responsible for finance and all contract negotiations.